湖北省国谈药可获得性研究——基于公立医院和零售药店的数据分析  

Study on the Availability of National Negotiated Drugs in Hubei Province--Based on the Data Analysis of Public Hospitals and Retail Pharmacies

作　　者：罗银 吴雨欣 杨赐然[1,2] 崔丹 LUO Yin;WU Yuxin;YANG Ciran;CUI Dan(School of Public Health,Wuhan University,WuhanHubei 430071,China;不详)

机构地区：[1]武汉大学公共卫生学院,湖北武汉430071 [2]武汉大学全球健康研究中心,湖北武汉430072

出　　处：《卫生经济研究》2024年第8期8-12,共5页

基　　金：比尔及梅琳达·盖茨基金会“完善中国医保制度研究”项目(OPP1199760)。

摘　　要：目的:评估国谈药在湖北省公立医院和零售药店的可获得性,为完善国谈药“落地”配套政策提供参考。方法:借鉴WHO/HAI标准药品调查法,通过品种配备率和可获得率指标,分析2022年处于协议期内275个国谈药在湖北省公立医院和零售药店的可获得性。结果:2022年湖北省国谈药在公立医院的可获得率为77.62%,各市州、各级别医药机构之间存在差距,国谈药各品种和各批次之间也存在明显差距;药店渠道的扩充使国谈药品种配备率提升。结论:国谈药在湖北省的“落地”供应存在地区差异,引入药店渠道能有效改善国谈药配备使用的公平性;需在政策设计上强化激励机制,引导公立医院配备使用国谈药,同时不断完善“双通道”药店管理机制,确保用药安全。Objective To evaluate the availability of national negotiated drugs in public hospitals and retail pharmacies in Hubei Province,and to provide reference for improving the supporting policies for the implementation of national negotiated drugs.Methods Drawing on the WHO/HAI standard drug survey method,the availability of 275 national negotiated drugs within the agreement period in public hospitals and retail pharmacies in Hubei Province in 2022 were analyzed by using the indicators of varieties allocation rate and availability rate.Results The availability rate of national negotiated drugs in public hospitals in Hubei Province in 2022 was 77.62%.However,there were significant differences in the availability of national negotiated drugs among cities and states,institutions at different levels,varieties and batches of drugs.The expansion of the pharmacy channels increased the allocation rate of national negotiated drugs.Conclusion There are regional differences in the supply of national negotiated drugs in Hubei Province,and the introduction of pharmacy channels can effectively improve the fairness of the provision and use of national negotiated drugs.It is necessary to strengthen the incentive mechanism in policy design to guide public hospitals to provide and use national negotiated drugs,and at the same time,continuously improve the"dual channel"pharmacy management mechanism to ensure the safety of drugs.

关 键 词：国家谈判药品 可获得性 公立医院 零售药店 

分 类 号：R19[医药卫生—卫生事业管理]